Uzum Ayse Kubat, Yucel Basak, Omer Beyhan, Issever Halim, Ozbey Nese Colak
Department of Internal Medicine, Division of Endocrinology and Metabolism, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Clin Endocrinol (Oxf). 2009 Jul;71(1):33-9. doi: 10.1111/j.1365-2265.2008.03423.x. Epub 2008 Sep 18.
Data regarding serum adipocytokine and ghrelin concentrations in different stages of anorexia nervosa (AN) is conflicting.
Our aim is to determine serum concentrations of adiponectin (ApN), leptin and ghrelin in different stages of AN and to evaluate their relationships with study parameters.
Study group was composed of four subgroups: Group 1: patients with a recent diagnosis of AN (n = 19); group 2: weight recovered (10% increase in body weight compared with baseline) subgroup of group 1 during follow-up (n = 10); group 3: recovered patients with a previous history of AN but normal menstrual cycles and body weight currently (n = 10); group 4: control group (n = 10). Venous blood was obtained for measurements of biochemical/hormonal parameters, ApN, leptin and ghrelin. Body composition was determined by bioimpedance analysis.
Changes in adipocytokine and ghrelin concentrations and relationships with anthropometric/biochemical parameters.
Leptin: fat mass (kg) ratio was significantly higher in group 1 patients compared with group 4 (4.3 +/- 4.6 vs. 1.1 +/- 0.5 microg/l kg, P < 0.01). No significant difference was observed among ghrelin concentrations. Leptin showed significant positive correlation with body fat mass in all groups. ApN showed significant positive association with body mass index in Group 1.
Leptin concentrations indexed to fat mass may indicate a nonphysiological higher set point of leptin per unit fat mass in treatment-naive AN patients. Correlation pattern between ApN and fat mass is modified also. Altered adipocytokine profile in AN may contribute to anorectic behaviour.
关于神经性厌食症(AN)不同阶段血清脂肪细胞因子和胃饥饿素浓度的数据相互矛盾。
我们的目的是确定AN不同阶段血清脂联素(ApN)、瘦素和胃饥饿素的浓度,并评估它们与研究参数的关系。
设计、地点和参与者:研究组由四个亚组组成:第1组:近期诊断为AN的患者(n = 19);第2组:第1组随访期间体重恢复(与基线相比体重增加10%)的亚组(n = 10);第3组:既往有AN病史但目前月经周期和体重正常的康复患者(n = 10);第4组:对照组(n = 10)。采集静脉血用于测量生化/激素参数、ApN、瘦素和胃饥饿素。通过生物电阻抗分析确定身体成分。
脂肪细胞因子和胃饥饿素浓度的变化以及与人体测量/生化参数的关系。
瘦素:第1组患者的瘦素与脂肪量(kg)之比显著高于第4组(4.3±4.6 vs. 1.1±0.5微克/升·千克,P < 0.01)。胃饥饿素浓度之间未观察到显著差异。在所有组中,瘦素与身体脂肪量呈显著正相关。在第1组中,ApN与体重指数呈显著正相关。
以脂肪量为指标的瘦素浓度可能表明未经治疗的AN患者每单位脂肪量的瘦素设定点非生理性升高。ApN与脂肪量之间的相关模式也发生了改变。AN中脂肪细胞因子谱的改变可能导致厌食行为。